<SEC-DOCUMENT>0000950142-21-001589.txt : 20210513
<SEC-HEADER>0000950142-21-001589.hdr.sgml : 20210513
<ACCEPTANCE-DATETIME>20210513172143
ACCESSION NUMBER:		0000950142-21-001589
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210326
FILED AS OF DATE:		20210513
DATE AS OF CHANGE:		20210513

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Freeman Robert Thomas
		CENTRAL INDEX KEY:			0001850414

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40295
		FILM NUMBER:		21920841

	MAIL ADDRESS:	
		STREET 1:		C/O ALIGNMENT HEALTHCARE, INC.
		STREET 2:		1100 W. TOWN & COUNTRY ROAD, SUITE 1600
		CITY:			ORANGE
		STATE:			CA
		ZIP:			92868

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Alignment Healthcare, Inc.
		CENTRAL INDEX KEY:			0001832466
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				465596242
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1100 W. TOWN AND COUNTRY ROAD
		STREET 2:		SUITE 1600
		CITY:			ORANGE
		STATE:			CA
		ZIP:			92868
		BUSINESS PHONE:		844-310-2247

	MAIL ADDRESS:	
		STREET 1:		1100 W. TOWN AND COUNTRY ROAD
		STREET 2:		SUITE 1600
		CITY:			ORANGE
		STATE:			CA
		ZIP:			92868
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>es210148619_3a-freeman.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3/A</documentType>

    <periodOfReport>2021-03-26</periodOfReport>

    <dateOfOriginalSubmission>2021-03-26</dateOfOriginalSubmission>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001832466</issuerCik>
        <issuerName>Alignment Healthcare, Inc.</issuerName>
        <issuerTradingSymbol>ALHC</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001850414</rptOwnerCik>
            <rptOwnerName>Freeman Robert Thomas</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ALIGNMENT HEALTHCARE, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>1100 W. TOWN &amp; COUNTRY ROAD, SUITE 1600</rptOwnerStreet2>
            <rptOwnerCity>ORANGE</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92868</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Financial Officer</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, par value $0.001 per share (&quot;Common Stock&quot;)</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>283916</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>879137</value>
                    <footnoteId id="F3"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F4"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>18</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F5"/>
            </exerciseDate>
            <expirationDate>
                <value>2031-03-25</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>762720</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Represents 116,506 shares of Common Stock of Alignment Healthcare, Inc. (the &quot;Company&quot;); 106,841 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO (as defined below) transaction-based incentive units, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's initial public offering (the &quot;IPO&quot;) and 50% on the second anniversary of the IPO, in each case, subject to Mr. Freeman's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based incentive units, according to the pre-IPO vesting schedule applicable to Mr. Freeman disclosed in the &quot;Executive Compensation - Outstanding Equity Awards at Fiscal Year End&quot; section of the Company's registration statement on Form S-1.</footnote>
        <footnote id="F2">Also represents 60,569 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on the first four anniversaries of the initial vesting date.</footnote>
        <footnote id="F3">Represents 381,535 shares of Common Stock of the Company and 497,602 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO transaction-based incentive units, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's IPO and 50% on the second anniversary of the IPO, in each case, subject to Mr. Freeman's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based incentive units, according to the pre-IPO vesting schedule applicable to Mr. Freeman disclosed in the &quot;Executive Compensation - Outstanding Equity Awards at Fiscal Year End&quot; section of the Company's registration statement on Form S-1.</footnote>
        <footnote id="F4">Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.</footnote>
        <footnote id="F5">Vest 25% on the first four anniversaries of the initial vesting date.</footnote>
    </footnotes>

    <remarks>This Form 3 amends and restates in its entirety the Form 3 filed by Mr. Freeman on March 26, 2021. The purpose of this Form 3 is to correct the form of ownership of 45,427 restricted stock units and 572,040 stock options which were inadvertently reported as being held indirectly in the original Form 3. Such restricted stock units and stock options are held directly by Mr. Freeman. This amendment does not affect Mr. Freeman's aggregate beneficial ownership of non-derivative and derivative securities of the Company.</remarks>

    <ownerSignature>
        <signatureName>/s/ Richard A. Cross, as Attorney-in-Fact, for Robert Thomas Freeman</signatureName>
        <signatureDate>2021-05-13</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
